Study flags Acholeplasma laidlawii as a duck surveillance concern

A newly published study is putting Acholeplasma laidlawii back on the radar for duck health. In a paper released October 8, 2026, researchers in Veterinary Sciences reported isolating A. laidlawii from the lungs and trachea of diseased ducks with air sac lesions, then showed in an experimental challenge that the organism could colonize ducks, remain detectable in swabs for more than two weeks, and induce mild histopathological changes even without obvious clinical illness. (mdpi.com)

That matters because A. laidlawii has long occupied a gray zone in veterinary microbiology. It’s widely distributed in the environment and is often described as an opportunistic or low-pathogenicity mollicute rather than a frontline poultry pathogen. Older reports documented its recovery from ducks and geese, but it has received far less attention than Mycoplasma gallisepticum or Mycoplasma synoviae in avian respiratory disease programs. A Brazilian review of avian mycoplasmosis characterized A. laidlawii and several other non-MG/MS mollicutes as organisms of limited or uncertain pathogenic importance, which helps explain why it has not been a routine surveillance target. (pubmed.ncbi.nlm.nih.gov)

The new study adds more concrete evidence of host association in ducks. According to the article abstract and indexing details, the isolate came from diseased ducks with air sac lesions, and antimicrobial susceptibility testing found relatively low MICs for tylvalosin, tylosin, and valnemulin. In the experimental phase, specific-pathogen-free ducks inoculated subcutaneously showed no clinical signs, but PCR detected the organism in oral and cloacal swabs from 5 to 21 days post-inoculation, and all lung and tracheal samples from infected ducks tested positive. Histopathology identified lesions in the lungs and trachea, leading the authors to conclude that A. laidlawii can colonize ducks and may represent an epidemiologic risk in duck farming. (mdpi.com)

The broader poultry literature supports a cautious reading. Earlier studies recovered A. laidlawii from ducks and goslings, including birds with airsacculitis and other inflammatory lesions, but those reports did not firmly establish how often the organism acts as a primary pathogen versus a secondary invader or commensal. More recent veterinary diagnostic commentary on mycoplasmas emphasizes that these organisms can be clinically important but also diagnostically tricky, especially when interpretation is confounded by prior antimicrobial exposure, concurrent infections, or simple detection of exposure rather than active disease. That context is important here: the new duck study strengthens biological plausibility, but it doesn’t yet settle the organism’s field-level impact in commercial production. (pubmed.ncbi.nlm.nih.gov)

No major industry reaction or formal regulatory response was evident in available sources at the time of writing. Still, the paper aligns with a broader surveillance mindset in animal health: USDA APHIS describes integrated surveillance as foundational to animal health, food safety, and public health, and emerging or overlooked agents often first surface through exactly this kind of case-based investigation. In that sense, the study may be less about declaring a new major duck pathogen and more about signaling that diagnosticians shouldn’t dismiss A. laidlawii automatically when it appears in respiratory samples from waterfowl. (aphis.usda.gov)

Why it matters: For veterinary professionals, the practical takeaway is diagnostic rather than alarmist. In ducks with respiratory signs, air sac lesions, or mixed infectious presentations, A. laidlawii may deserve consideration alongside better-known bacterial and mycoplasmal agents, particularly if routine testing is unrevealing. The reported in vitro susceptibility to tylvalosin, tylosin, and valnemulin is notable, but treatment decisions still need to be grounded in jurisdiction-specific drug approvals, flock context, residue considerations, and the possibility of coinfections. Just as importantly, this study highlights the risk of overlooking subclinical colonizers that may contribute to chronic respiratory burden, transmission, or misleading lab findings. (mdpi.com)

What to watch: The next questions are whether other groups replicate these findings in field flocks, whether prevalence studies show A. laidlawii is more common in ducks than currently appreciated, and whether future work can separate simple carriage from meaningful production or welfare effects. If that evidence builds, duck surveillance panels and respiratory disease investigations may start treating A. laidlawii as a more routine organism of interest rather than a microbiologic footnote. (mdpi.com)